12341.jpg
grandfather-and-grandson-reading-at-lake-555799527-5ac7c84143a1030036c1b221_edited.jpg

Improving Quality of Life

through Transcatheter Cardiac Repair (TCR)

 

Micro Interventional Devices (MID) is a privately held medical device company that designs, manufactures and commercializes disruptive catheter-based technologies for the treatment of structural heart disease.

MID(2021_01_28)_023.JPG
0897-rev-a-mia-clr.png

The MIA-T Percutaneous Tricuspid Annuloplasty System for the treatment of Tricuspid Regurgitation

 

MID develops Transcatheter Cardiac Repair (TCR) technologies that eliminate the need for cardiopulmonary bypass.

The Company strives to improve structural heart disease outcomes for the:

 

Patient: Through less invasive and less morbid procedures.

Surgeon/Interventionalist: Through technology that improves outcomes, reduces operative time and/or improves ease of use.

Healthcare Network: Through cost effective technologies that reduce operative time while exceeding surgical and/or interventional performance criteria.

unnamed.jpeg

MIA-T Is an Investigational Device ONLY